4arthritisinfo.co.uk Rotating Header Image

PharmaGap pairs with Swiss firm to work on arthritis and multiple sclerosis drugs (Ottawa Business Journal)

PharmaGap ( TSX-V:GAP ) has teamed up with a Swiss bioscience company to develop drugs that could be used to treat diseases such as arthritis and multiple sclerosis.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Propeller
  • StumbleUpon
  • Technorati
  • TwitThis

Comments are closed.